Madrid, Spain

Paloma Mendez

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pharma Mar, S.a.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paloma Mendez. Retrieved from https://idiyas.com/inventor/paloma-mendez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paloma Mendez: Innovator in Antitumoral Research

Introduction

Paloma Mendez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral agents. Her innovative work has led to the creation of valuable patents that aim to improve cancer treatment.

Latest Patents

Paloma Mendez holds a patent for "Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them." This invention relates to aplidine derivatives that are useful for the treatment of tumors. The patent showcases her dedication to advancing medical science and providing new solutions for cancer therapy. She has 1 patent to her name.

Career Highlights

Paloma Mendez is currently employed at Pharma Mar, S.A., a company known for its focus on innovative cancer treatments. Her role at Pharma Mar has allowed her to work on groundbreaking research that has the potential to change the landscape of cancer therapy.

Collaborations

Throughout her career, Paloma has collaborated with notable colleagues, including Ignacio Rodriguez and Concepción Polanco. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Paloma Mendez is a trailblazer in the field of antitumoral research, with a focus on developing effective treatments for cancer. Her contributions through her patent and work at Pharma Mar highlight her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…